Yasumoto K - Search Results

1

Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy.

Sugaya M, Takenoyama M, Osaki T, Yasuda M, Nagashima A, Sugio K, Yasumoto K. Sugaya M, et al. Among authors: yasumoto k. Chest. 2002 Jul;122(1):282-8. doi: 10.1378/chest.122.1.282. Chest. 2002. PMID: 12114371

2

Establishment of an immortalized T-cell line from lung cancer tissue: phenotypic and functional analyses.

Imahayashi S, So T, Sugaya M, Yasuda M, Eifuku R, Takenoyama M, Hanagiri T, Yoshimatsu T, Oyama T, Yasumoto K. Imahayashi S, et al. Among authors: yasumoto k. Int J Clin Oncol. 2002 Feb;7(1):38-44. doi: 10.1007/s101470200004. Int J Clin Oncol. 2002. PMID: 11942048

3

[Future prospects for specific immunotherapy].

Sugaya M, Takenoyama M, Yasumoto K. Sugaya M, et al. Among authors: yasumoto k. Nihon Rinsho. 2002 May;60 Suppl 5:609-13. Nihon Rinsho. 2002. PMID: 12101747 Review. Japanese. No abstract available.

4

Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.

Ichiki Y, Takenoyama M, Mizukami M, So T, Sugaya M, Yasuda M, So T, Hanagiri T, Sugio K, Yasumoto K. Ichiki Y, et al. Among authors: yasumoto k. J Immunol. 2004 Apr 15;172(8):4844-50. doi: 10.4049/jimmunol.172.8.4844. J Immunol. 2004. PMID: 15067062

5

A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.

So T, Takenoyama M, Ichiki Y, Mizukami M, So T, Hanagiri T, Sugio K, Yasumoto K. So T, et al. Among authors: yasumoto k. Cancer. 2005 Jan 1;103(1):200-8. doi: 10.1002/cncr.20782. Cancer. 2005. PMID: 15573370 Free article.

6

Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy.

Ichiki Y, Hanagiri T, Takenoyama M, Baba T, Fukuyama T, Nagata Y, Mizukami M, So T, Sugaya M, Yasuda M, So T, Sugio K, Yasumoto K. Ichiki Y, et al. Among authors: yasumoto k. Lung Cancer. 2005 May;48(2):281-9. doi: 10.1016/j.lungcan.2004.10.017. Epub 2004 Dec 22. Lung Cancer. 2005. PMID: 15829330

7

Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.

So T, Takenoyama M, Mizukami M, Ichiki Y, Sugaya M, Hanagiri T, Sugio K, Yasumoto K. So T, et al. Among authors: yasumoto k. Cancer Res. 2005 Jul 1;65(13):5945-52. doi: 10.1158/0008-5472.CAN-04-3787. Cancer Res. 2005. PMID: 15994973

8

Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.

Nagata Y, Hanagiri T, Takenoyama M, Fukuyama T, Mizukami M, So T, Ichiki Y, Sugaya M, Sugio K, Yasumoto K. Nagata Y, et al. Among authors: yasumoto k. Clin Cancer Res. 2005 Jul 15;11(14):5265-72. doi: 10.1158/1078-0432.CCR-04-2542. Clin Cancer Res. 2005. PMID: 16033845

9

A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.

Takenoyama M, Baurain JF, Yasuda M, So T, Sugaya M, Hanagiri T, Sugio K, Yasumoto K, Boon T, Coulie PG. Takenoyama M, et al. Among authors: yasumoto k. Int J Cancer. 2006 Apr 15;118(8):1992-7. doi: 10.1002/ijc.21594. Int J Cancer. 2006. PMID: 16287085

10

Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.

Fukuyama T, Hanagiri T, Takenoyama M, Ichiki Y, Mizukami M, So T, Sugaya M, So T, Sugio K, Yasumoto K. Fukuyama T, et al. Among authors: yasumoto k. Cancer Res. 2006 May 1;66(9):4922-8. doi: 10.1158/0008-5472.CAN-05-3840. Cancer Res. 2006. PMID: 16651449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters